Local- and systemic-mediated suppression of contact hypersensitivity in mice by several structurally unrelated

E Kodari1, A Pavone, J J Reiners

  • 1Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Smithville 78957.

Carcinogenesis
|October 11, 1991
PubMed

Insights

Various tumor promoters, including TPA and anthralin, suppress the immune response known as contact hypersensitivity (CHS). Some promoters achieve this suppression through both local and systemic effects in mice.

Area of Science:

  • Immunology
  • Toxicology
  • Carcinogenesis

Background:

  • Contact hypersensitivity (CHS) is a T-cell mediated immune response.
  • Murine skin multistage carcinogenesis protocol identifies chemical promoters.
  • Tumor promoters can influence immune responses.

Purpose of the Study:

  • To investigate the effect of structurally unrelated chemical promoters on contact hypersensitivity (CHS) in SENCAR mice.
  • To determine if tumor promoters share the ability to suppress CHS.
  • To explore the local and systemic mechanisms of CHS suppression by promoters.

Main Methods:

  • Mice were sensitized with 2,4-dinitrofluorobenzene (DNFB) and challenged to induce CHS.
  • Dorsal skin was pretreated with various chemical promoters (TPA, anthralin, etc.) before sensitization.
  • Ventral skin was also pretreated with some promoters to assess systemic effects.

Main Results:

  • Pretreatment with multiple promoters (TPA, anthralin, etc.) significantly inhibited DNFB-induced CHS.
  • Benzoyl peroxide showed diminished CHS suppression compared to other promoters.
  • Local and systemic application of TPA, anthralin, and EPP suppressed CHS, with local application being more potent.

Conclusions:

  • Structurally unrelated tumor promoters share the common ability to suppress CHS.
  • Some tumor promoters can suppress CHS through both local and systemic mechanisms.
  • These findings highlight a potential link between chemical carcinogenesis and immune modulation.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...